Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow CHINA PHARMA HOLDINGS, INC.

Get SEC filing alerts via email and in your feed for CHINA PHARMA HOLDINGS, INC.

CPHI

CHINA PHARMA HOLDINGS, INC.

About CHINA PHARMA HOLDINGS, INC.

China Pharma Holdings Inc., through its subsidiary Hainan Helpson Medical and Biotechnology Co., Ltd., develops, manufactures, and markets prescription pharmaceutical products in China. Its portfolio includes generic drugs, first-to-market generics, and modern Traditional Chinese Medicines targeting high-incidence diseases like cardiovascular, CNS, infectious, and digestive conditions. Operating GMP-certified facilities, Helpson sells primarily to hospitals and pharmacies via a national distribution network, leveraging academic-driven promotion and regulatory compliance to maintain competitive positioning in China’s pharmaceutical market.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from CHINA PHARMA HOLDINGS, INC.

1
1
CHINA PHARMA HOLDINGS, INC. China Pharma Holdings Reports Q1 2026 Revenue Decline and Increased Net Loss

Via official filing (AI summary) | 19 days ago | 0 comments

2
1
CHINA PHARMA HOLDINGS, INC. China Pharma Holdings Reports $4.1 Million Revenue for Fiscal Year 2025, Faces Increased Competition

Via official filing (AI summary) | 2 months ago | 0 comments

3
1
CHINA PHARMA HOLDINGS, INC. China Pharma Holdings Reports Decline in Revenue and Net Loss for Q3 and Nine Months of 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
CHINA PHARMA HOLDINGS, INC. China Pharma Holdings Reports Revenue Decline and Improved Gross Loss for Six Months Ended June 30, 2025

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
CHINA PHARMA HOLDINGS, INC. China Pharma Holdings Reports $1.14 Million Revenue in Q1 2025, Faces Increased Competition

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
CHINA PHARMA HOLDINGS, INC. China Pharma Holdings Reports 36% Revenue Decline and Gross Loss for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
CHINA PHARMA HOLDINGS, INC. China Pharma Holdings Reports Significant Financial Challenges, Decline in Revenue and Gross Loss

Via official filing (AI summary) | over 1 year ago | 0 comments